Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Extension Study on the Safety and Efficacy of IgPro10 in Patients With Primary Immunodeficiency (PID)

NCT00322556 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT00322556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00322556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Extension Study on the Safety and Efficacy of IgPro10 in Patients With Primary Immunodeficiency (PID)
Lead sponsor
CSL Behring
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2005
Completion date
April 30, 2008
Enrollment
55 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

agammaglobulinemia, common variable immunodeficiency, igg deficiency